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Cardiovasc Surg. 2009;138:309-15.Implantation of a Sapien XT aortic bioprosthesis with the NovaFlex
catheter through a subclavian accessBertrand Marcheix, MD, PhD,a Etienne Grunenwald, MD,a Didier Carrie, MD, PhD,b and
Nicolas Dumonteil, MD,b Toulouse, FranceTranscatheter aortic bioprosthesis implantation is a new op-
tion for patients at high surgical risk with severe symptom-
atic aortic valve stenosis.1 The main alternatives to
transfemoral access are currently the transapical approach
with an Edwards Sapien prosthesis (Edwards Lifesciences,
Inc, Irvine, Calif) and the subclavian approach with the
Medtronic CoreValve prosthesis (Medtronic, Inc, Minneap-
olis, Minn),2 with some observational and noncontrolled
data indicating that the latter could be less invasive.3 The
subclavian approach was not developed with the new gener-
ation Sapien XT bioprosthesis delivered by its NovaFlex
catheter (Edwards Lifesciences) because of theoretic tech-
nical issues, including difficulties in aligning the prosthesis
over the balloon in the patient, outside the delivery sheath in
the ascending aorta.
We report the implantation of a Sapien XT bioprosthe-
sis with the NovaFlex catheter through a left subclavian
approach.
CLINICAL SUMMARY
An 82-year-old woman was referred for symptomatic se-
vere aortic stenosis with New York Heart Association func-
tional dyspnea class III, indexed effective orifice area of0.45 cm2/m2, mean gradient of 38 mmHg, maximal gradient
of 61 mm Hg, peak aortic jet velocity of 3.7 m/s, stroke vol-
ume of 70 mL, and left ventricular ejection fraction of 25%.
The patient had a history of diabetes mellitus, obesity
(body mass index 36.7 kg/m2), chronic obstructive and re-
strictive pulmonary disease (forced expiratory volume in
1 second of 800 mL [55%], forced vital capacity of 1.4 L
[56%]), peripheral artery disease, and coronary artery
disease with history of previous percutaneous coronary in-
tervention on the left anterior descending artery with no re-
maining significant stenosis. Low-dose (15 mg) dobutamine
echocardiography detected contractile reserve (effective or-
ifice area of 0.49 cm2/m2. mean gradient of 49mmHg, max-
imal gradient of 75 mm Hg, peak aortic jet velocity of
4.3 m/s, stroke volume of 87 mL, and left ventricular ejec-
tion fraction of 37%).
A transcatheter aortic valve implantation was proposed,
because this patient was considered a high-risk surgical
candidate for whom conventional surgery was contraindi-
cated (logistic EuroSCORE of 46.48%, Society of Thoracic
Surgeons Score of 13.4%).
The aortic annulus, as measured by transesophageal
echocardiography, was 24 mm. The iliofemoral arteries
were not suitable for transarterial access (Figure 1, A). A
transapical approach was contraindicated because of severe
respiratory dysfunction. The computed tomographic scan
showed a left subclavian artery without stenosis with a di-
ameter of 8 mm (Figure 1, B and C) and a distance of
13.6 mm between the aortic annulus and the ostium of the
left subclavian artery (Figure 1, D and E).
The procedure was performed with the patient under gen-
eral anesthesia through surgical cutdown and isolation of
the left axillary artery. After heparinization (50 UI/kg, acti-
vated clotting time of 200–250 seconds), the 19F sheath was
directly inserted in the axillary artery toward the aortic arch
over an Amplatz extra stiff wire (Cook Medical Inc,rdiovascular Surgery c Volume 143, Number 3 753
FIGURE 1. A, Multislice computed tomography showing calcified iliofemoral vessels (red arrow, ostia of the primary iliac arteries; yellow arrow, primary
iliac arteries; green arrows, external iliac arteries). B, Multislice computed tomographic reconstruction showing left axillary artery (red arrow). C, Multi-
slice computed tomographic reconstruction showing left axillary artery (red arrow). D, Multislice computed tomography demonstrating the aortic annulus,
the ascending aorta, the aortic arch, and the ostium of the left subclavian artery. E, Multislice computed tomographic reconstruction demonstrating the dis-
tance between the aortic annulus (red arrow) and the ostium of the left subclavian artery (green arrow).
Surgical TechniquesBloomington, Ind), which allowed clear attenuation of the
axillary tortuosities (Figure 2, A). A 26-mm Edwards Sa-
pien XT valve was then inserted with the NovaFlex catheter
after a balloon aortic valvuloplasty (23 mm) performed
through the 19F sheath. Alignment of the prosthesis over
the balloon was easily performed within the ascending aorta
and the aortic arch (Figure 2, B). The prosthesis was then
classically implanted with the flex portion of the NovaFlex
catheter under fluoroscopic and transesophageal echocar-
diographic guidance and under right ventricular rapid pac-
ing (temporary pacing lead placed from the right femoral
vein).
Angiographic and echocardiographic control exami-
nations showed good positioning, with no significant
intravalvular or perivalvular regurgitation (Figure 2,
C). After surgical suture of the axillary artery, a final
angiographic check did not show any arterial injury
(Figure 2, D).
The postoperative course was uneventful. At discharge
(day 7), the patient was in New York Heart Association754 The Journal of Thoracic and Cardiovascular Surgfunctional class II. Transthoracic echocardiography showed
left ventricular ejection fraction of 33%, prosthesis mean
gradient of 10 mm Hg, indexed effective orifice area of
1.69 cm2, and no paravalvular leak.DISCUSSION
The axillary subclavian approach has been reported with
the Medtronic CoreValve bioprosthesis. Modine and col-
leagues demonstrated that the axillary approach was safe
and that positioning and controlling the prosthesis was eas-
ier than with the retrograde transfemoral approach.4
To date, the subclavian access has been reported once
with the RetroFlex catheter (Edwards Lifesciences).5 Con-
cerning the NovaFlex catheter, the main issues were the
suitability of the 19F Edwards sheath within the tortuosities
of the subclavian artery and the possibility of alignment of
the prosthesis over the balloon.
The insertion of the 19F Edwards sheath over the extra
stiff guidewire allowed clear attenuation of subclavianery c March 2012
FIGURE 2. A, A 19F sheath (red arrow)with its dilator introduced into the left axillary subclavian artery over the stiff wire. B, Alignment of the Sapien XT
prosthesis (red arrow; Edwards Lifesciences, Inc, Irvine, Calif) on the NovaFlex balloon catheter (blue arrow; Edwards Lifesciences) inside the ascending
aorta and the aortic arch. C, Final angiographic control examination after implantation of the 26-mm Sapien XT prosthesis showing optimal positioning,
with no significant paravalvular leakage. D, Final angiographic control of the left subclavian axillary artery after withdrawal of the 19F sheath, showing
neither dissection nor arterial injury.
Surgical Techniquesartery tortuosities. We did not observe any kinking of the
sheath in this patient, and the prosthesis was easily inserted.
The alignment of the prosthesis over the balloon was per-
formed between the distal part of the sheath and the aortic
annulus. A minimal distance of 10 cm appears to be neces-
sary for correct alignment. This distance needs to be docu-
mented on preoperative computed tomographic scan
(Figure 1, D).
To our knowledge, this case is the first implantation of
a Sapien XTaortic bioprosthesis with the NovaFlex catheter
through an axillary subclavian approach. As an alternative
to transfemoral access, this approach could be considered
feasible with the Edwards XT valve.The Journal of Thoracic and CaReferences
1. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Trans-
catheter aortic-valve implantation for aortic stenosis in patients who cannot un-
dergo surgery. N Engl J Med. 2010;363:1597-607.
2. Asgar AW,Mullen MJ, Delahunty N, Davies SW, DalbyM, Petrou M, et al. Trans-
catheter aortic valve intervention through the axillary artery for the treatment of
severe aortic stenosis. J Thorac Cardiovasc Surg. 2009;137:773-5.
3. Petronio AS, De Carlo M, Bedogni F, Marzocchi A, Klugmann S, Maisano F, et al.
Safety and efficacy of the subclavian approach for transcatheter aortic valve implan-
tation with the CoreValve revalving system. Circ Cardiovasc Interv. 2010;3:359-66.
4. Modine T, Obadia JF, Choukroun E, Rioufoul G, Sudre A, Laborde JC, et al. Trans-
cutaneous aortic valve implantation using the axillary/subclavian access: feasibility
and early clinical outcomes. J Thorac Cardiovasc Surg. 2011;141:487-91, 491.e1.
5. Sharp AS, Michev I, Colombo A. First trans-axillary implantation of Edwards Sa-
pien valve to treat an incompetent aortic bioprosthesis. Catheter Cardiovasc Inter-
vent. 2010;75:507-10.rdiovascular Surgery c Volume 143, Number 3 755
